Effects of tiletamine-xylazine-tramadol combination and its specific antagonist on AMPK in the brain of rats

1. Belinda J.H., Halla M.C., Jane R.H., Graham A.J.: Flumazenilindependent positive modulation of γ-aminobutyric acid action by 6-methylflavone at human recombinant α1β 2γ2L, and α1β2 GABAA receptors. Eur J Pharmacol 2004, 491, 1–8.10.1016/j.ejphar.2004.03.014Search in Google Scholar

2. Culmsee C., Monnig J., Kemp B.E., Mattson M.P.: AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Molec Neurosci 2001, 17, 45–58.10.1385/JMN:17:1:45Search in Google Scholar

3. Cetrullo S., D’Adamo S., Tantini B., Borzi R.M., Flamigni F.: mTOR, AMPK, and Sirt1: key players of metabolic stress management. Critical Rev Eukaryotic Gene Exp 2015, 25, 59–75.10.1615/CritRevEukaryotGeneExpr.2015012975Search in Google Scholar

4. Craps J., Joris V., De J.B., Sonveaux P., Horman S., Lengelé B., Bertrand L., Many M.C., Colin I.M., Gérard A.C.: Involvement of mTOR and regulation by AMPK in early iodine deficiency-induced thyroid microvascular activation. Endocrinology 2016, 157, 2545–2559.10.1210/en.2015-1911Search in Google Scholar

5. Dyck J.R., Kudo N., Barr A.J., Davies S.P., Hardie D.G., Lopaschuk G.D.: Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5’-AMP activated protein kinase. Eur J Biochem 1999, 262, 184–190.10.1046/j.1432-1327.1999.00371.xSearch in Google Scholar

6. Dong D., Cai G., Ning Y., Wang J.C., Lv Y., Hong Q., Cui S.Y., Fu B., Guo Y.N., Chen X.M.: Alleviation of senescence and epithelial-mesenchymal transition in aging kidney by short-term caloric restriction and caloric restriction mimetics via modulation of AMPK/mTOR signaling. Oncotarget 2017, 8, 16109–16121.10.18632/oncotarget.14884Search in Google Scholar

7. Fan H.G., Wang H.B., Hu K.: Dynamic effect of the compound anesthetic for miniature pigs on cAMP signal transduction system in different brain regions of SD rats. Chinese Vet Sci 2010, 40, 421–428.Search in Google Scholar

8. Joungmok K., Mondira K., Benoit V., Kun-Liang G.: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biology 2011, 13, 132-141.10.1038/ncb2152Search in Google Scholar

9. Haapalinna A., Sirviö J., Macdonald E., Virtanen R., Heinonen E.: The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats. Eur J Pharmacol 2000, 387, 141–150.10.1016/S0014-2999(99)00819-5Search in Google Scholar

10. Kasajima A., Pavel M., Darb-Esfahani S., Davies S.P., Hardie D.G., Lopaschuk G.D.: mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 2011, 18, 181–192.10.1677/ERC-10-0126Search in Google Scholar

11. Kolesnikova T.O., Khatsko S.L., Shevyrin V.A., Morzherin Y.Y., Kalueff A.V.: Effects of a non-competitive N-methyl-daspartate (NMDA) antagonist, tiletamine, in adult zebrafish. Neurotoxicol Teratol 2016, 59, 62–67.10.1016/j.ntt.2016.11.00927916716Search in Google Scholar

12. Kim E., Park M., Jeong J., Kim H., Lee S.K., Lee E., Oh B.H., Namkoong K.: Cholinesterase inhibitor donepezil increases mitochondrial biogenesis through AMP-activated protein kinase in the hippocampus. Neuropsychobiology 2016, 73, 81–91.10.1159/000441522Search in Google Scholar

13. Girvan C.B., Dundee J.W.: Alterations in response to somatic pain associated with anaesthesia xxlll: further study of naloxone. Brit J Anaesth 1976, 48, 463–468.10.1093/bja/48.5.463Search in Google Scholar

14. Lu D.Z., Fan H.G., Wang H.B., Hu K., Zhang J.T., Yu S.M.: Effect of the addition of tramadol to a combination of tiletaminezolazepam and xylazine for anaesthesia of miniature pigs. Vet Rec 2010, 167, 489–492.10.1136/vr.c4458Search in Google Scholar

15. Lu D.Z.: Study on the wake up mechanism of the anesthetic agent for miniature swine. Harbin, China: Northeast Agricult Univer 2011, S858.28.Search in Google Scholar

16. Li L., Dong J., Lu D., Duarte Q.L., Sheng J., Fan H.G.: Effects of iletamine-zolazepam-xylazine-tramadol combination on biochemical and haematological parameters in cats. Bull Vet Inst Pulawy 2012, 56, 369–372.10.2478/v10213-012-0064-7Search in Google Scholar

17. Livak K.J., Schmittgen T.D.: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods-A Companion To Methods in Enzymology 2001, 25, 402-408.10.1006/meth.2001.1262Search in Google Scholar

18. Madhusoodanan K.S., Murad F.: NO-cGMP signaling and regenerative medicine involving stem cells. Neurochem Res 2007, 32, 681–694.10.1007/s11064-006-9167-ySearch in Google Scholar

19. Nakayama T., Hashimoto T., Nagai Y.: Involvement of glutamate and gamma-aminobutyric acid (GABA)-ergic systems in thyrotropin-releasing hormone-induced rat cerebellar cGMP formation. Eur J Pharmacol 1996, 316, 157–164.10.1016/S0014-2999(96)00614-0Search in Google Scholar

20. Organization W.H.: WHO Expert Committee on Drug Dependence. Thirty-sixth report, World Health Organization; New York, Columbia University Press, International Documents Service, 2015, 998, 1–34.Search in Google Scholar

21. Price T.J., Dussor G.: AMPK: An emerging target for modification of injury-induced pain plasticity. Neurosci Letters 2013, 557, 9–18.10.1016/j.neulet.2013.06.060384411123831352Search in Google Scholar

22. Perouansky M.: Coagulation, flocculation, and denaturation: a century of research into protoplasmic theories of anesthesia. Anesth Analg 2014, 119, 311–320.10.1213/ANE.000000000000028725046786Search in Google Scholar

23. Radbruch L., Grond S., Lehmann K.A.: A risk-benefit assessment of tramadol in the management of pain. Drug Saf 1996, 15, 8–29.10.2165/00002018-199615010-000028862961Search in Google Scholar

24. Sleeman J., Stevens R., Ramsay E.: Field immobilization of muskrats (Ondatra zibethicus) for minor surgical procedures. J Wildl Dis 1997, 33, 165–168.10.7589/0090-3558-33.1.165Search in Google Scholar

25. Seo J.P., Son W.G., Gang S., Lee I.: Sedative and analgesic effects of intravenous xylazine and tramadol on horses. J Vet Sci 2011, 12, 281–286.10.4142/jvs.2011.12.3.281Search in Google Scholar

26. Sheng J.: Effects of miniature swine combined anesthetics and its antagonist on PI3K/Akt/mTOR signaling pathway in different brain regions of rats. Harbin, China: Northeast Agricult Univer 2015, S857.124.Search in Google Scholar

27. Springer A., Razafimanantsoa L., Fichtel C., Kappeler P.M.: Comparison of three short-term immobilization regimes in wild verreaux’s sifacas (Propithecus verreauxi) ketamine-xylazine, ketamine-xylazine-athropine, and tiletamine-zolozepam. J Zoo Wildlife Med 2015, 46, 482–490.10.1638/2014-0154.1Search in Google Scholar

28. Shi X.X., Yin B.S., Peng Y., Chen H., Li X., Su L.X., Fan H.G., Wang H.B.: Xylazine activates adenosine monophosphateactivated protein kinase pathway in the central nervous system of rats. Plos One 2016, 11, e0153169.10.1371/journal.pone.0153169Search in Google Scholar

29. Vulliemoz Y., Whittington R.A., Virag L.: The nitric oxidecGMP system of the locus coeruleus and the hypnotic action of alpha-2 adrenergic agonists. Brain Res 1999. 849, 169–174.10.1016/S0006-8993(99)02147-2Search in Google Scholar

30. Vacher C.M., Hardin-Pouzet H., Steinbusch H.W., Morzherin Y.Y., Kalueff A.V.: The effects of nitric oxide on magnocellular neurons could involve multiple indirect cyclic GMP-dependent pathways. Eur J Neurosci 2003, 17, 455–466.10.1046/j.1460-9568.2003.02467.x12581164Search in Google Scholar